Are you the publisher? Claim or contact us about this channel

Embed this content in your HTML


Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog

Channel Description:

Visit One News Page for Health Insurance news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Health Insurance news headlines.

older | 1 | .... | 916 | 917 | (Page 918) | 919 | 920 | .... | 952 | newer

    0 0

    A partnership led by development firm Hines closed escrow Thursday on the land for health insurance giant Centene Corp.'s planned 5,000-employee campus in North Natomas. Sacramento beat out Austin, Texas and Phoenix to be chosen as the site for the St. Louis-based company's western hub, with city leaders cuttting a $13.5 million tax credit deal with Centene (NYSE: CNC). We spoke with Sacramento Mayor Darell Steinberg about the deal, which will bring the largest new employer to the city in years. What… Reported by bizjournals 1 day ago.

    0 0

    Compulsory health insurance for over-40s should be introduced to help meet the rising cost of adult social care, says the leader of Staffordshire County Council. Reported by Express and Star 17 hours ago.

    0 0

    [East African] Tanzania is working on a model that will help ensure that every citizen enjoys health insurance. Reported by 4 hours ago.

    0 0

    Reported by SeekingAlpha 6 days ago.

    0 0

    Driverless technology might actually add as many jobs as it destroys, but the new roles will be 'the worst trucking jobs around' **

    · *The trucking industry is expected to be disrupted by driverless technology in the coming decades.*
    · *There are 1.8 million truck drivers in the US.*
    · *A new report by University of Pennsylvania sociologist Steve Viscelli suggests that not all 1.8 million jobs will be lost by driverless trucks. In fact, many will be replaced by the expansion of "autonomous truck ports," where local drivers will bring goods to the driverless trucks.*
    · *Those new jobs, though, are likely to emulate existing port driving jobs, which are poorly-paid, less likely to have benefits, and average 59 hours a week of work. *


    Autonomous vehicles were forecasted last year to threaten "more than four million jobs," the vast majority being careers in heavy truck driving.

    Silicon Valley seems keen to hasten the arrival of those driverless trucks. Starsky Robotics, for instance, said it will put driverless trucks on the road as early as this year.

    Once again, it appears the robots are taking over — and working-class Americans will lose, yet again. 

    A new report by University of Pennsylvania sociologist Steve Viscelli diverges from that narrative. Driverless technology may add as many jobs as it takes away, Viscelli wrote.

    Based off extensive research and interviews with tech companies, trucking manufacturers and firms, drivers, unions, academics, and others, the report indicates that around 294,000 jobs would be lost in a world with autonomous trucks. Many of the lost jobs would be in long-distance trucking, which involve transporting goods for hundreds of miles a day over the highway. 

    Still, it's projected that there will be enough jobs added to accommodate displaced drivers. These will be found in sectors like local driving and transporting goods to what he calls autonomous truck ports (ATPs). 

    Here's the situation he wrote was most feasible in the near-future:

    "Human drivers would take care of non-driving tasks and navigate complicated local streets, then swap trailers with self-driving trucks at an autonomous truck port (ATP) next to the highway. The autonomous truck would handle the long-distance freeway driving, then hand off the load at an ATP near the destination."

    **Enough jobs would exist for displaced drivers, but they wouldn't be good ones**

    Industry experts aren't worried that driverless technology would destroy all driving jobs, but it is likely to nix tens of thousands of some of the best jobs in trucking, as well as relatively well-paid jobs.

    Around 51,000 jobs in less-than-truckload driving, for example, are at risk of displacement from autonomous technology. These drivers bring shipments from different customers to one destination, but they do relatively little non-driving work and mostly drive on the highway. That means they're particularly likely to be replaced by driverless trucks.

    And that's a major loss. Many of these workers are unionized, and the average pay in less-than-truckload driving is $69,208. 

    Compare that to the average pay of port drivers: $35,000. This segment is expected to boom as autonomous trucking expands, because these drivers will be needed to transport goods from factories or warehouses to the autonomous trucks before those vehicles hit the highway. 

    However, they're "among the worst trucking jobs around," Viscelli wrote. Port drivers are less likely to have health insurance or retirement benefits, work an average of 59 hours a week, and are usually classified as independent contractors rather than employees. 

    "Twenty-five years from now, there will likely be many more jobs moving goods than there are today," Viscelli wrote. 

    "(T)he jobs created by autonomous trucks will pay far less than the jobs we might lose," he continued. "The risk of autonomous trucks is not that there won’t be enough jobs for American truckers, it’s that there won’t be enough good jobs."

    Are you a truck driver with a story about the industry? Email the author at

    Click here to explore the entire report, commissioned by the Working Partnerships USA and the UC Berkeley Labor Center.

    *SEE ALSO: Silicon Valley believes driverless trucks and drones will soon transform how we get things — but truckers and warehouse workers disagree*

    *DON'T MISS: One of the biggest problems facing self-driving trucks has little to do with the technology*

    Join the conversation about this story »

    NOW WATCH: How Publishers Clearing House makes $1 billion a year Reported by Business Insider 5 hours ago.

    0 0

    Dublin, Sept. 17, 2018 (GLOBE NEWSWIRE) -- The "Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)" report has been added to *'s* offering.The global market for human vaccines is experiencing strong growth, fuelled by favorable demographics (population growth, rising life expectancy), continued new product introductions, indication expansions for some products and rising usage, particularly in India and China. Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments examines the market for vaccines used in humans to prevent various types of disease, providing a comprehensive market summary.*Issues and Trends in the Market*Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention to date. As a result, vaccine-preventable diseases and their resulting deaths are now relatively rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues are impacting the vaccines industry both positively and negatively. Vaccines 2018 discusses some of the most important macro and micro trends, including:

    · Rising life expectancy;
    · increasing obesity;
    · growing out of pocket spending on healthcare;
    · health insurance changes in the U.S.;
    · decentralization of healthcare services;
    · austerity programs in Europe;
    · global healthcare mergers and acquisitions;
    · vaccine safety challenges and negative public opinion;
    · vaccine shortages;
    · refusal to vaccinate.

    *Competitive Landscape*

    The report also discusses the vaccine businesses of industry leaders as well as emerging players with high potential. Many of the larger companies - some active in other areas in addition to vaccines - are discussed, with a focus on their preventative vaccine businesses and products. (Specifically excluded is discussion of related infectious disease products such as therapeutic vaccines and monoclonal antibodies.)*

    *Key Topics Covered:*1. Executive Summary
    The Global Vaccines Industry
    Scope and Methodology
    Market Estimates and Forecasts

    2. Introduction to Vaccines
    A Brief History: The Development of Vaccines
    The Human Immune System
    Vaccine Mechanism of Action
    Types of Vaccines
    Attenuated (Weakened) Live Viruses
    Killed (Inactivated) Viruses
    Toxoid Vaccines
    Genetically Engineered/Modified Vaccines
    Vaccine Approval Process

    3. Pediatric Preventative Vaccines
    Childhood Immunization in the United States
    Childhood Immunization Rates
    Challenges to the Vaccine Delivery System
    Recommended Childhood Immunization Schedule
    State Immunization Recommendations
    United Nations Initiatives
    Pediatric Vaccine Products
    Dengue Fever
    Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
    Haemophilus Influenzae Type B
    Hand, Foot & Mouth Disease
    Hepatitis A
    Measles, Mumps and Rubella
    Meningococcal Disease
    Pneumococcal Conjugate
    Respiratory Syncytial Virus
    Pediatric Vaccines in Development
    The World Market for Pediatric Preventive Vaccines
    Total Market Size and Forecast
    Hepatitis Vaccine Market
    Haemophilus Influenzae Type B Vaccine Market
    Measles, Mumps and Rubella Vaccines
    Combination Vaccines Market
    Pneumococcal Vaccine
    Poliovirus Vaccine
    Varicella Vaccines
    Other Pediatric Vaccines

    4. Adult Preventative Vaccines
    Global Influenza Surveillance Program
    U.S. Surveillance
    Recommended Adult Immunizations
    WHO International Health Regulations
    Adult Vaccine Products
    Cervical Cancer
    Japanese Encephalitis
    Nosocomial Infections
    Pneumococcal Disease
    Typhoid Fever
    Yellow Fever
    Adult Vaccines in Development
    The World Market for Adult Preventive Vaccines
    Total Market Size and Forecast
    Cervical Cancer Market
    Hepatitis Market
    Influenza Vaccine Market
    Pneumococcal Vaccine Market
    Travel and Other Vaccine Market

    5. Total Vaccines Market
    Trends Driving the Vaccines Market
    Market Size and Forecast
    Vaccine Sales by Region
    Vaccine Market Competitors
    Pediatric Vaccines
    Adult Vaccines

    6. Issues and Trends
    Rising Life Expectancy
    Increasing Obesity
    Addiction Epidemic
    Growing Out of Pocket Spending on Healthcare
    Health Insurance Changes in the U.S.
    Affordable Care Act Changes
    Reimbursement Changes and Value-Based Care
    Decentralization of Healthcare Services
    Urgent Care Centers
    Retail Clinics
    Austerity Programs in Europe
    Other Nations
    Global Healthcare Mergers and Acquisitions
    Vaccine Safety
    Refusal to Immunize
    Post-Licensure Surveillance
    The Vaccine Injury Compensation Program
    World Health Organization
    Other Initiatives
    Pricing Pressure
    Cost of Vaccines in the United States
    Vaccine Shortages
    Preventing Shortages in the Developed Countries
    Preventing Shortages in Developing Nations
    U.S. National Vaccine Plan
    Vaccines and Bioterrorism
    Project Bioshield Act
    National Bio and Agro-Defense Facility
    Vaccine Treatment and Evaluation Units
    New Disease Threats
    Stimulating Vaccine Development
    Global Health Vaccine Center of Innovation
    Human Vaccines Project
    Innovations in Vaccine Delivery Systems
    Mucosal Delivery
    Intranasal Delivery

    7. Company Profiles

    · Bavarian Nordic A/S
    · Bharat Biotech
    · Crucell /Johnson & Johnson
    · CSL Limited
    · Daiichi Sankyo Co. Ltd.
    · Emergent Biosolutions
    · GlaxoSmithKlin
    · Hawaii Biotech
    · Medimmune
    · Merck & Co. Inc.
    · Mymetics
    · PaxVax
    · Pfizer
    · Sanofi Pasteur
    · Serum Institute of India Pvt. Ltd.
    · Soligenix
    · Takeda Pharmaceutical Co. Ltd.
    · Valneva

    For more information about this report visit
    Laura Wood, Senior Manager
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Cervical Cancer Drugs , Cancer Vaccines, Pediatrics Reported by GlobeNewswire 15 hours ago.

    0 0

    NITI Aayog Member Dr. V K Paul to Inaugurate MTaI MedTekon 2018 *NITI Aayog* Member *Dr. Vinod K. Paul* will inaugurate *MTaI MedTekon 2018* in New Delhi on 20^th September as industry leaders come together to envision the role of MedTech industry in the implementation of Ayushman Bharat, formally known as *Pradhan Mantri Jan Arogya Yojana (PMJAY)*.


    Dr. Paul is Head of Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, since 1985. Prof. Paul has been closely associated with India’s reproductive, maternal, newborn and child health programs in various roles for over three decades. He is member of NITI Aayog since August 2017.


    The seminar will also have the presence of *Mr. Indu Bhushan*, Chief Executive Officer of Ayushman Bharat-National Health Protection Mission and National Health Agency (NHA), along with representatives of Ministry of Health and Family Welfare, Indian Alliance of Patients' Group, Insurance companies, PE Funds, private hospitals and diagnostic industry.


    Foreign delegates will share the global experience of implementing similar healthcare programmes in their countries. The former undersecretary, Department of Health, Govt. of Philippines, *Dr. Teodoro J Herbosa*, who played a key role in rolling out Philippines Public Healthcare Programme has also confirmed his presence to share his country’s experience with the policymakers of India.


    This is the first seminar where representatives spanning the entire medical technology sector will be present to talk about Ayushman Bharat, which indicates the importance the MedTech industry attaches to this pathbreaking programme. Industry Captains from different MedTech associations will huddle together to plan how they can unitedly contribute to the successful implementation of Ayushman Bharat.


    The government is launching Ayushman Bharat on 25th September to finance secondary and tertiary healthcare in the country. The scheme will provide health insurance worth Rs. 5 lakh per household and will cover 50 crore people or nearly 40% of India’s population.


    During MTaI MedTekon 2018, MTaI will unveil a theme paper entitled “*MedTech – The Keystone for Ayushman Bharat*” that would define the challenges and opportunities in implementing the scheme. “Ayushman Bharat is the largest public healthcare scheme in the world. Given the scale of implementation, it is extremely important that all stakeholders should be in sync with the programme objective and implementation roadmap. At the same time, it is necessary that concerns of all stakeholders are addressed. MTaI MedTekon 2018 will bring together all stakeholders for a day of constructive discussion,” *MedTekon Chairman Mr. Badhri Iyengar* said.


    *More details on MTaI MedTekon 2018* are available at


    *About Medical Technology Association of India*

    Medical Technology Association of India (MTaI – pronounced as Em-tai) is a not-for-profit organization duly registered under sub-section (2) of section 7 of the Companies Act, 2013 and Rule 8 of the Companies (Incorporation) Rules, 2014.


    MTaI is an association of research-based medical technology companies who have made remarkable investments in Manufacturing, R&D and Health Care Workers Training in India. MTaI represents a wide spectrum of the medical device industry with global experience in innovation and manufacturing. All the time stressing on the three hallmarks of healthcare - Quality, Consistency and Patient Safety, MTaI wants to be a responsible voice of the industry. The association is committed to improving access to affordable and quality healthcare for patients.


    MTaI looks to partner with the Government of India in setting a roadmap for the growth of medical devices sector by bringing in even bigger investments in this sector, through '*Make in India*’ and through technology upgradation and dissemination in the provider space.


    Join MTaI on Facebook: @mtaiorg | Twitter: @mtaiorg | Website:

      Reported by NewsVoir 15 hours ago.

    0 0

    A partnership led by development firm Hines closed escrow Thursday on the land for health insurance giant Centene Corp.'s planned 5,000-employee campus in northwestern Sacramento. Sacramento beat out Austin, Texas, and Phoenix to be chosen as the site for the St. Louis-based company's western hub, with city leaders cutting a $13.5 million tax credit deal with Centene (NYSE: CNC). We spoke with Sacramento Mayor Darell Steinberg about the deal, which will bring the largest new employer to the city… Reported by bizjournals 11 hours ago.

    0 0

    September’s month-long observance is a good reminder for pet owners to be proactive with their aging pets

    STAMFORD, Conn. (PRWEB) September 17, 2018

    In observance of Healthy Aging Month, the American Pet Products Association (APPA) expresses the importance of healthy aging for our pets too, not just ourselves. According to APPA’s 2017-2018 National Pet Owners Survey, over 50 percent of dog and cat owners feel their pet is like a family member and close to 9 million dogs and 4.7 million cats even have health insurance. There is no question that today’s pet owners want the best for their pets and September is a good reminder to make health a priority at any stage of life. Below is a list of products manufactured by APPA members that will help pets live their best life at any age.

    Healthy Eating

    Treating pets with Ostrich Jerky Treats by Mosaic Pet Food are a guilt-free option for pet owners wanting to give a reward. New allergies can come on later in life, and Ostrich is an excellent alternative protein source for dogs that may be allergic to other common proteins. Mosaic Jerky Treats are naturally loaded with Omega-3 fatty acids, which may support skin conditions and weight disorders as well.
    Price: $13.99 – $14.99

    Superfood Blends by Billy + Margot provide pets with great nutrition for a healthy life and balanced diet. All formulas have a high percentage of protein with a combination of superfoods and absolutely no grains. Their Circle of Nutrition model ensures their food sustains, enhances, connects and thrives every pet’s health.
    Price: Starting at $19.99


    Sometimes our aging pets need a little something to pick them up. Pet Vitality™ by Omega Alpha is a combination of formulations for stress, energy, mobility, immune health and joint health for cats and dogs. This supplement supports many natural healing pathways for pets that may need an extra source of nutrients to get them back to feeling their best.
    Price: $36.99

    Avoid the “limp & gimp” with Mobility Supplement Blend by WINPRO Containing a blend of animal blood proteins and other key ingredients to support canine joint function and maintain joint mobility, help pets feel in their prime, especially during times of increased activity.
    Price: $12.99

    For all stages of life, Fetch Fuel by Presidio Natural Pet Co. provides pets with three unique formulas to help with their mobility, skin, coat and digestive health. Each formula is loaded with natural ingredients that provide pets with overall wellness. Plus, it’s easy to serve, just drizzle over food with the convenient squeezable pouch.
    Price: $24.99

    Smooth Movin’

    Jumping in and out of cars is hard on dogs’ joints, and can lead to injuries. The Ramp4Paws roll-up dog ramp helps dogs enter and exit vehicles without any problems. It even comes with a convenient grab bag for easy transport and storage.
    Price: Starting at $189.95

    Does Fido seem a little sore after an all-day hike? Hot & Cold Pet Therapy Wraps by Caldera is a wrap system designed for dogs’ aches and pains.
    The easy-to-use system of reusable gel packs and coordinating wraps aids in the care of soft tissue injuries as well as supports post-operative recovery. They can be cooled in the freezer or warmed in the microwave and are secured with Velcro™ and with a quick release buckle, wraps can have a customized fit.
    Price: Starting at $68.99

    For aging pets, mobility is life. PawFriction by Pawtology is a paw pad coating system designed by a veterinarian to improve quality of life for aging dogs and those with orthopedic or neurological conditions. It provides a layer of the paw padding systen to decrease sliding on smooth floors, increase mobility and reduce the risk of injury. This product was designed to give pets the ability and confidence to get around safely and easily.
    Price: $34.99

    Additional information, product samples, images and interview opportunities available upon request.


    The American Pet Products Association (APPA) is the leading trade association serving the interests of the pet products industry since 1958. APPA membership includes more than 1,200 pet product manufacturers, their representatives, importers and livestock suppliers representing both large corporations and growing business enterprises. APPA's mission is to promote, develop and advance pet ownership and the pet product industry and to provide the services necessary to help its members prosper. APPA is also proud to grow and support the industry through the following initiatives: Pets Add Life (PAL), the Human Animal Bond Research Institute (HABRI), The Pet Leadership Council (PLC), the Pet Industry Joint Advisory Council (PIJAC), Bird Enjoyment and Advantage Koalition (BEAK), and the Pet Care Trust. Visit for more information. Reported by PRWeb 11 hours ago.

    0 0

    Delivery Trust® Email Encryption continues to grow their partner program. Providing Erickson Dental Technologies with email security to their entire client network.

    IRVINE, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID), a trusted leading provider of HIPAA (Health Insurance Portability and Accountability Act) compliant email security, achieves continued success in providing secure communication to their partners. Erickson Dental Technologies selected Delivery Trust® to secure email communications for the dental clients they serve nationally.Erickson Technologies has served the nations most advanced dental practices for almost 30 years. Erickson provides computer-based technologies for practices across the nation. They focus on all technical aspects of the practice, so the dental providers can focus on the patients. They have an outstanding reputation due to their extensive knowledge of dental practice workflow and providing the technology which creates a superior patient experience. They deliver the latest technology for dentists with extraordinary customer service.

    Jeff Erickson, President of Erickson Dental Technologies, states, “At Erickson Dental Technologies our goal is to provide our clients with the most advanced technologies, we see their communications no different. The partnership with Identillect has been forged to provide our clients with the most simple and secure communication on the market. We anticipate significant adoption by our clients as we continue to serve all of their technical needs.”

    Data breaches have almost doubled from Q4 2017 to Q1 2018 in the medical sector. As reported in HIPAA Journal, most of these breaches could have been prevented with the use of encryption. Dental care is the fastest growing segment in the healthcare industry. Due to this growth the federal government has stepped up HIPAA enforcement, conducting more compliance audits and seeking more financial penalties from HIPAA violators. 

    Todd Sexton, CEO of Identillect Technologies, comments, “The trend of dental practitioners leveraging external resources for support in operations, administration and business development is an intelligent division of labor, allowing dental professionals to focus on doing what they do best, patient care. Erickson Dental Technologies is well respected in the dental industry, understanding the technical and security needs of their clients and handling it on their behalf.”

    Email confidentiality notices and disclaimers — There’s a myth that including a confidentiality notice or disclaimer in an email makes the email compliant with HIPAA and allows a dentist to send PHI via unencrypted or unsecure email. The myth is false. Even the best-worded notice or disclaimer will not make an unencrypted email comply with HIPAA. The rules here still apply.

    For more information, please visit

    On Behalf of the Board of Directors of:


    Todd Sexton
    Chief Executive Officer
    Tel: (949) 468-7878

    *About Identillect*
    Identillect Technologies is the leading provider of the email encryption service Delivery Trust®, empowering enterprises of all sizes to protect their business and their client’s critical information against cyber security attacks. 

    Delivery Trust® is an award - winning, multi-platform plug-in, which gives users complete control of their emails, for one low price. One simple integration complies with all regulations and most importantly provides peace of mind. 

    For more information, or your free trial, please visit

    *About Erickson Dental Technologies*
    Erickson Technologies has served the nations most advanced dental practices for have chosen for almost 30 years. Erickson provides computer-based technologies for practices across the nation. They focus all technical aspects of the practice, so the dental providers can focus on the patients. They have an outstanding reputation due to our extensive knowledge of the dental practice workflow and the technology which provides superior patient outcomes and experiences. They deliver the latest technology for dentists with extraordinary customer service.

    Erickson Technologies holds one of the highest reputation in the industry. With over 15,000 dental systems installed and serviced throughout the nation, Erickson prevails as the stable leading force in a rapidly changing industry, transforming the standard dental office into a versatile and ergonomically sound environment.

    Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. Reported by GlobeNewswire 11 hours ago.

    0 0


    Press Release

    First-half financial information at June 30, 2018
    IFRS - Regulated information - Audited

    *Cegedim: EBITDA margin improved in the first half of 2018*

    · Health insurance, HR and e-services division EBITDA rose 33.5%
    · EBITDA fell at the Healthcare professionals division
    · Outlook confirmed

    *Disclaimer: This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. This press release may contain inside information. It was sent to Cegedim's authorized distributor on September 17, 2018, no earlier than 5:45 pm Paris time.*
    *The terms "business model transformation" and "BPO" are defined in the glossary.*
    *Owing to the disposal of the Group's Cegelease and Eurofarmat businesses, announced in 2017 and completed on February 28, 2018, the consolidated 2017 and 2018 financial statements are presented according to IFRS 5, "Non-current assets held for sale and discontinued". The Group also applies IFRS 15, "Revenue from contracts with customers". See the annexes for more details.*

    *FR*: +33 1 72 72 74 03 *US*: +1 844 286 0643 *UK*: +44 207 1943 759 *PIN* *Code*: 35537485#
    *Webcast at: *

    *Boulogne-Billancourt, France, September 17, 2018 after the market close*

    Cegedim*, an innovative technology and services company, posted consolidated H1 2018 revenues from continuing activities of €227.6 million, up 1.6% on a reported basis and 1.8% like for like compared with the same period in 2017. First-half EBITDA came to €33.3 million, up 11.8% year on year. EBITDA margin improved from 13.3% a year earlier to 14.6% in H1 2018.*

    Health insurance, HR and e-services division revenues rose 6.6%, while Healthcare professionals division revenues fell 6.9%. The BPO business delivered a noteworthy performance, boosting sales by 14.0% over the second quarter of 2018 and posting revenues of €17.9 million for the first half, an 11.2% improvement over the same period in 2017. EBITDA rose by 33.5% at the Health insurance, HR and e-services division, but fell 42.4% at the Healthcare professionals division.

    In 2018, the Group is fine-tuning the updated business model it first adopted in 2015.

    *Income statement summary*

    *Consolidated revenues from continuing activities* for the first half of 2018 came to €227.6 million, up 1.6% as reported. Excluding a currency headwind of 0.7% and a positive impact from acquisitions of 0.4%, revenues rose 1.8%. In like-for-like terms, revenues rose 6.0% at the Health insurance, HR and e-services division and fell 5.2% at the Healthcare professionals division.

    *EBITDA *rose by €3.5 million, or 11.8%, to €33.3 million. The margin increased from 13.3% in H1 2017 to 14.6%. The main reasons for the EBITDA trend were a decrease in purchases consumed and external expenses, set against an increase in personnel costs.

    *Depreciation and amortization costs* climbed by €1.8 million to €21.4 million, compared with €19.5 million in first half 2017. Amortization of R&D expenses notably increased by €1.0 million over the period.

    *EBIT before special items* increased by €1.7 million, or 16.7%, to €11.9 million. The margin improved to 5.2% in the first half of 2018 compared with 4.6% in H1 2017.

    *Exceptional items* in the first half of 2018 amounted to a €9.6 million charge, against an €11.7 million charge in the year-earlier period. The decline was mainly attributable to a drop in intangible fixed asset amortization linked to assets set to become obsolete, partly offset by an increase in restructuring costs, including €4 million in fees related to the Cegelease divestment.

    *Net cost of financial debt* decreased by €1.2 million, or 35.3%, to €2.2 million in first half 2018 compared with €3.4 million in first half 2017. The decrease reflects the positive impact of refinancing deals struck in the first half of 2017.

    *Tax* amounted to a charge of €0.8 million in H1 2018 compared with a €1.2 million charge in H1 2017, chiefly due to the recognition of deferred tax assets in France.

    As a result*, consolidated net profit attributable to the Group *was a profit of €0.7 million versus a loss of €3.8 million in 2017.* Consolidated net profit from continuing activities* was a loss of €0.7 million compared with a loss of €6.1 million in the year-earlier period. *Earnings per share before special items* was a profit of €0.2 per share against a loss of €0.1 in H1 2017. *Earnings per share* amounted to €0.0 compared with a loss of €0.3 in 2017.

      *H1 2018* *H1 2017* *Chg.*
      *€m* % *€m* % %
    *Revenues* *227.6* 100.0 *224.1* 100.0 *+1.6%*
    EBITDA *33.3* 14.6 *29.8* 13.3 +11.8%
    Depreciation & amortization *(21.4)* (9.4) *(19.5)* (8.7) +9.3%
    *EBIT before special items* *11.9* 5.2 *10.2* 4.6 *+16.7%*
    Special items *(9.6)* (4.2) *(11.7)* (5.2) (17.8)%
    *EBIT* *2.3* 1.0 *(1.5)* (0.7) *n.m.*
    Cost of net financial debt *(2.2)* (1.0) *(3.4)* (1.5) (35.2)%
    Tax expenses *(0.8)* (0.3) *(1.2)* (0.5) (36.8)%
    *Consolidated net profit from continuing activities* *(0.7)* (0.3) *(6.1)* (2.7) *(89.2)%*
    Net earnings from activities held for sale *0.0* 0.0 *2.4* 1.1 n.m.
    Net earnings from activities sold *1.3* 0.6 *0.0* 0.0 -
    *Profit attributable to the owners of the parent* *0.7* *0.3* *(3.8)* *(1.7)* *n.m.*
    EPS before special items *0.2* - *(0.1)* - n.m.
    EPS *0.0* - *(0.3)* - n.m.

    *Analysis of business trends by division*

    · Key figures by division

        *Revenues* * * *EBIT before special items* * * *EBITDA*
    In € million   H1 2018 H1 2017   H1 2018 H1 2017   H1 2018 H1 2017
    Health insurance, HR and e-services   149.5 140.3   13.4 8.8   24.2 18.1
    Healthcare professionals   76.2 81.8   (0.9) 4.6   6.9 12.0
    Corporate and others   1.9 2.0   (0.6) (3.2)   2.2 (0.3)
    *Cegedim* * * *227.6* *224.1* * * *11.9* *10.2* * * *33.3* *29.8*

    · Health insurance, HR and e-services

    *The division's H1 2018 revenues came to €149.5 million, up 6.6% as reported. The March 30, 2018, **Rue de la Paye** acquisition in France boosted revenues by 0.7%. Currency translation had virtually no impact. Like-for-like revenues rose 6.0% over the period.*
    *H1 2018 EBITDA rose 33.5%, to €24.2 million, compared with €18.1 million in H1 2017. The EBITDA margin improved to 16.2%, 3.3 percentage points higher than a year ago.*

    The Health insurance, HR and e-services division represented 65.7% of consolidated revenues from continuing activities, compared with 62.6% over the same period a year earlier.

    The businesses that made the biggest contributions to first-half revenue growth were Cegedim SRH (HR management solutions), Cegedim e-business (digitalization and data exchange), sales statistics for pharmaceutical products, and third-party payment flow management in France. The businesses that made the biggest contributions to first-half EBITDA growth were Cegedim SRH, sales statistics for pharmaceutical products, Cegedim e-business, and third-party payment flow management in France.

    · Healthcare professionals

    *The division's H1 2018 revenues came to €76.2 million, down 6.9% as reported. Currency translation was a 1.7% headwind. Acquisitions and divestments had virtually no impact. Like-for-like revenues fell 5.2% over the period.*
    *H1 2018 EBITDA fell 42.4%, to €6.9 million, compared with €12.0 million in H1 2017. The EBITDA margin contracted to 9.1%, 5.6 percentage points lower than a year ago.*

    The Healthcare professionals division represented 33.5% of consolidated revenues from continuing activities, compared with 36.5% over the same period a year earlier.

    As expected, first-half revenue were hampered by the doctor computerization businesses in the US, the UK and Spain ahead of the release of new versions, whose impact will not be felt until 2019. EBITDA fell mainly because of doctor computerization activities in the US and Spain, and pharmacy computerization in France owing to a demanding comparison.

    · Corporate and others

    *The division's H1 2018 revenues came to €1.9 million, down 2.8% as reported and like for like. Currency translation, acquisitions and divestments had no impact.*
    *H1 2018 EBITDA rose €2.5 million to €2.2 million, compared with a €0.3 million loss in H1 2017.*

    The Corporate and others division represented 0.9% of consolidated revenues from continuing activities in H1 2018, the same as in H1 2017.

    EBITDA growth is attributable to the performance of Cegedim_IT.

    *Balance sheet structure*

    *Acquisition goodwill *was €173.3 million at June 30, 2018, compared with €167.8 million at end-December 2017. The €5.5 million increase, or 3. 3%, was chiefly attributable to the €6.5 million impact of the Rue de la paye acquisition in France. Acquisition goodwill represented 29.2% of the total balance sheet at June 30, 2018, compared with 22.5% at December 31, 2017.

    * Cash and equivalents *amounted to €13.6 million at June 30, 2018, down €5.1 million compared with December  31, 2017.

    *Shareholders' equity *rose €2.3 million, or 1.2%, to €195.0 million at June 30, 2018, compared with €197.3 million at December 31, 2017. The increase was primarily due to an additional €8.7 million of Group reserves, which were partly offset by a €0.7 million negative movement in currency translation reserves and the €10.5 million decline in Group net profit. Shareholders' equity represented 32.9% of the total balance sheet at end-June 2018 compared with 26.4% at end-December 2017.

    *Net financial debt* amounted to €159.7 million, a drop of €76.5 million versus six months ago. This debt represented 81.9% of shareholders' equity and liabilities at June 30, 2018, down from 119.7% at December 31, 2017.

    The Group generated *operating free cash flow *of €11.4 million compared with €6.1 million at end-2017. The €5.2 million improvement was chiefly attributable to reductions in WCR and in acquisitions of tangible and intangible fixed assets, partly offset by a decline in gross cash flow.


    · Bpifrance sells Cegedim shares

    Bpifrance Participations sold 1,682,146 Cegedim shares via an accelerated bookbuilding process to French and international institutional investors at a price of €35 per share on February 13, 2018. In the context of the transaction, the shareholders' agreement dated October 28, 2009, between Mr. Jean-Claude Labrune, FCB (the family holding company controlled by Mr. Labrune), and Bpifrance - as well as the concert between the parties - has been terminated. Following the sale, Cegedim's free float increased to 44% of capital (vs. 32% before the transaction).

    · Cegelease and Eurofarmat definitively sold

    On February 28, 2018, Cegedim announced that it had completed the disposal of Cegelease and Eurofarmat to FRANFINANCE of the Société Générale Group for an amount of €57.5 million plus reimbursement of the shareholder's loan account, which amounted to €13 million. Of this amount, Cegedim used €30 million to pay down its debt.

    The parties have decided that Cegelease and the Cegedim Group will continue to collaborate in France under the current terms as part of a six-year collaboration agreement.

    · Rue de la Paye acquired in France

    On March 30, 2018, Cegedim acquired French company Rue de la Paye via its Cegedim SRH subsidiary. The deal will enable the Group to market digital payroll solutions to 2 million SMEs and small businesses in France, including - importantly - thousands of healthcare professionals that are already Cegedim Group clients.

    Rue de la Paye's 2017 revenues were equivalent to around 1% of 2017 consolidated Group revenues, and it earned a profit. It began contributing to the Group's consolidation scope in April 2018.

    · Tax

    On February 21, 2018, Cegedim S.A. received notice that French tax authorities would perform an audit of its accounts covering the period January 1, 2015, to December 31, 2016.

    To the best of the company's knowledge, there were no events or changes after the accounts were closed that would materially alter the Group's financial situation.

    *Significant post-closing transactions and events*

    · Independent director appointed to Cegedim SA's board

    At the annual general meeting on August 31, 2018, shareholders appointed Ms. Béatrice Saunier to a six-year term as an independent director. Her term will expire following the AGM held to approve the financial statements for the year 2023.

    To the best of the company's knowledge, there were no events or changes after the accounts were closed that would materially alter the Group's financial situation.


    · Cautiously optimistic for 2018

    Building on the efforts that it executed with success in 2017, Cegedim continues to pursue its strategy of focusing on organic growth, fueled by a policy of sustained innovation.

    For 2018, the Group expects modest like-for-like revenue and EBITDA margin growth. Most of the full-year margin improvement will have taken place in the first half.

    The Group does not issue any earnings estimates or forecasts.

    · Potential impact of Brexit

    Cegedim deals in local currency in the UK, as it does in every country where it is present. Thus, Brexit is unlikely to have a material impact on the Group's consolidated EBIT margin before special items.

    With regard to healthcare policy, the Group has not identified any major European programs at work in the UK.

    The figures cited above include guidance on Cegedim's future financial performances. This forward-looking information is based on the opinions and assumptions of the Group's senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to Chapter 2 points 4.2, "Risk factors and insurance", and 5.5, "Outlook", of the 2017 Registration Document filed with the AMF on March 29, 2018, under number D.18-0219.

    *Financial calendar*

      *September 18, 2018,* at 2:30 pm CET

    *October 25, 2018,* after the market close

    *December 11, 2018,* at 2:00 pm CET SFAF meeting

    Q3 2018 revenues

    9^th Investor Summit
    *September 17, 2018, at 6:15 pm CET*
    The Group will hold a conference call hosted by Jan Eryk Umiastowski, Cegedim Chief Investment Officer and Head of Investor Relations.

    The webcast is available at the following address:

    The H1 2018 results presentation is available on the website and on the Group's financial communications app, Cegedim IR.


    *Contact numbers**:* *France:* +33 1 72 72 74 03
    *US: *+1 844 286 0643 
    *UK and others:* +44 20 71943 759 *PIN* code: *35537485#*

    *Additional information*

    The Audit Committee and the Board of Directors met on September 17, 2018, to review the consolidated financial statements for the first half of 2018. The statutory auditors conducted a limited review of the financial statements. The statutory auditors' report is dated September 17, 2018.

    Cegedim Group revenues take into account the initial application of IFRS 15 on January 1, 2018. IFRS 15 does not significantly alter the Group's revenues relative to the principles and methods of revenue recognition used prior to its application.

    The Group has created systems and tools to identify potentially significant contracts, as well as any changes in the characteristics or volume of business over time that may require additional analysis in respect of IFRS 15.


    *Balance sheet as June 30, 2018*

    · Assets as December 31, 2018

    In thousands of euros *06.30.2018* *12.31.2017*
    *Goodwill on acquisition* *173 293* *167 758*
    Development costs 41 964 22 887
    Other intangible fixed assets 109 275 122 962
    *Intangible fixed assets* *151 239* *145 849*
    Property 544 544
    Buildings 3 839 4 127
    Other tangible fixed assets 29 007 28 057
    Construction work in progress 1 444
    *Tangible fixed assets* *33 391* *33 172*
    Equity investments 1 214 913
    Loans 12 875 12 986
    Other long-term investments 5 455 6 454
    *Long-term investments - excluding equity shares in equity method companies* *19 544* *20 353*
    Equity shares in equity method companies 10 351 10 072
    Government - Deferred tax 28 902 27 271
    Accounts receivable: Long-term portion 147 210
    Other receivables: Long-term portion  
    Financial instruments 629 622
    *Non-current assets* *417 495* *405 308*
    Services in progress 72 78
    Goods 3 448 3 567
    Advances and deposits received on orders 323 325
    Accounts receivables: Short-term portion 109 982 118 170
    Other receivables: Short-term portion 38 688 71 220
    Cash equivalents 153 8 000
    Cash 13 430 10 718
    Prepaid expenses 9 921 8 989
    *Current Assets* *176 017* *221 068*
    Asset of activities held for sale - 119 847
    *Total Assets* *593 512* *746 223*

    · Liabilities ans shareholders' equity as of June 30, 20188

    In thousands of euros *06.30.2018* *12.31.2017*
    Share capital 13 337 13 337
    Group reserves 186 568 177 881
    Group exchange gains/losses -5 663 -5 008
    Group earnings 655 11 147
    *Shareholders' equity. Group share* *194 898* *197 357*
    Minority interests (reserves) 121 -25
    Minority interests (earnings) 29 14
    Minority interests 150 -11
    *Shareholders' equity* *195 047* *197 346*
    Long-term financial liabilities 171 059 250 830
    Long-term financial instruments 1 025 928
    Deferred tax liabilities 7 128 6 362
    Non-current provisions 26 208 25 445
    Other non-current liabilities 37 56
    *Non-current liabilities* *205 457* *283 621*
    Short-term financial liabilities 2 185 4 040
    Short-term financial instruments 1 2
    Accounts payable and related accounts 40 872 46 954
    Tax and social liabilities 77 756 83 118
    Provisions 3 016 3 025
    Other current liabilities 69 178 65 098
    *Current liabilities* *193 007* *202 236*
    Liabilities of activities held for sale - 63 020
    *Total Liabilities* *593 512* *746 223*

    · Income statements as of June 30, 2018

    In thousands of euros *06.30.2018* 06.30.2017
    *Revenue* *227 633* *224 069*
    Purchased used -15 365 -16 723
    External expenses -58 501 -65 018
    Taxes -4 640 -4 030
    Payroll costs -114 566 -108 259
    Allocations to and reversals of provisions -2 327 -1 329
    Change in inventories of products in progress and finished products -6 -
    Other operating income and expenses -229 -417
    Income of equity-accounted affiliates 1 315 1 493
    *EBITDA* *33 316* *29 787*
    Depreciation expenses -21 369 -19 546
    *Operating income before special items* *11 947* *10 241*
    Depreciation of goodwill - -
    Non-recurrent income and expenses -9 633 -11 719
    *Other exceptional operating income and expenses* *-9 633* *-11 719*
    *Operating income* *2 314* *-1 478*
    Income from cash and cash equivalents 1 077 125
    Gross cost of financial debt -4 048 -4 372
    Other financial income and expenses 748 811
    *Cost of net financial debt* *-2 222* *-3 436*
    Income taxes -1 546 -125
    Deferred taxes 793 -1 066
    *Total taxes* *-752* *-1 191*
    Share of profit (loss) for the period of equity method companies - -1
    Profit (loss) for the period from continuing activities -661 -6 107
    Profit (loss) for the period from discontinued activities 1 345 2 358
    Consolidated profit (loss) for the period 684 -3 748
    *Consolidated Net income (loss) attributable to owners of the parent* 655 -3 767
    Minority interests *29* *19*
    Average number of shares excluding treasury stock 13 941 543 13 975 365
    *Current Earnings Per Share (in euros)* *0,2* *-0,1*
    *Earnings Per Share (in euros)* *0,0* *-0,3*
    Dilutive instruments Néant Néant
    *Earning for recurring operation per share (in euros)* *0,0* *-0,3*

    · Consolidated cash flow statement as of June 30, 2018

    In thousands of euros *06.30.2018* 06.30.2017
    Consolidated profit (loss) for the period 684 -3 748
    Share of earnings from equity method companies -1 315 -1 492
    Depreciation and provisions 26 609 33 941
    Capital gains or losses on disposals - -266
    *Cash flow after cost of net financial debt and taxes* *25 978* *28 435*
    Cost of net financial debt 2 276 3 267
    Tax expenses 39 2 349
    *Operating cash flow before cost of net financial debt and taxes* *28 293* *34 051*
    Tax paid -697 -2 212
    Change in working capital requirements for operations: requirement - -
    Change in working capital requirements for operations: surplus 11 549 3 810
    *Cash flow generated from operating activities after tax paid and change in working capital requirements (A)* *39 145* *35 650*
    Of which net cash flows from operating activities of held for sales -5 145 1 047
    Acquisitions of intangible assets -22 208 -23 897
    Acquisitions of tangible assets -5 662 -5 849
    Acquisitions of long-term investments -2 437
    Disposals of tangible and intangible assets 88 225
    Disposals of long-term investments - 464
    Change in loans made and cash advance 106 -9 812
    Impact of changes in consolidation scope 64 550 -3 008
    Dividends received from outside Group 1 969
    *Net cash flows generated by investment operations (B)* *36 405* *-41 878*
    Of which net cash flows connected to investment operations of activities held for sales 13 892 85
    Dividends paid to parent company shareholders - -
    Dividends paid to the minority interests of consolidated companies -55 -13
    Capital increase through cash contribution - -
    Loans issued - 10 500
    Loans repaid -82 038 -3 106
    Interest paid on loans -1 628 -2 963
    Other financial income and expenses paid or received -1 362 -468
    *Net cash flows generated by financing operations (C)* *-85 083* *3 950*
    Of which net cash flows related to financing operations of activities held for sales -13 073 132
    *Change In Cash without impact of change in foreign currency exchange rates (A + B + C)* *-9 533* *-2 279*
    Impact of changes in foreign currency exchange rates 112 -420
    *Change in cash* *-9 421* *-2 699*
    Opening cash 22 998 20 722
    Closing cash 13 577 18 024*BPO (Business Process Outsourcing):* BPO is the contracting of non-core business activities and functions to a third-party provider. Cegedim provides BPO services for human resources, Revenue Cycle Management in the US and management services for insurance companies, provident institutions and mutual insurers.

    *Business model transformation:* Cegedim decided in fall 2015 to switch all of its offerings over to SaaS format, to develop a complete BPO offering, and to materially increase its R&D efforts. This is reflected in the Group's revamped business model. The change has altered the Group's revenue recognition and negatively affected short-term profitability

    *Corporate and others:* This division encompasses the activities the Group performs as the parent company of a listed entity, as well as the support it provides to the three operating divisions.

    *EPS:* Earnings Per Share is a specific financial indicator defined by the Group as the net profit (loss) for the period divided by the weighted average of the number of shares in circulation.

    *Operating expenses:* Operating expenses is defined as purchases used, external expenses and payroll costs.

    *Revenue at constant exchange rate:* When changes in revenue at constant exchange rate are referred to, it means that the impact of exchange rate fluctuations has been excluded. The term "at constant exchange rate" covers the fluctuation resulting from applying the exchange rates for the preceding period to the current fiscal year, all other factors remaining equal.

    *Revenue on a like-for-like basis:* The effect of changes in scope is corrected by restating the sales for the previous period as follows:

    by removing the portion of sales originating in the entity or the rights acquired for a period identical to the period during which they were held to the current period; similarly, when an entity is transferred, the sales for the portion in question in the previous period are eliminated. *Life-for-like data (L-f-l):* At constant scope and exchange rates.

    *Internal growth:* Internal growth covers growth resulting from the development of an existing contract, particularly due to an increase in rates and/or the volumes distributed or processed, new contracts, acquisitions of assets allocated to a contract or a specific project.   *External growth:* External growth covers acquisitions during the current fiscal year, as well as those which have had a partial impact on the previous fiscal year, net of sales of entities and/or assets.

    *EBIT:* Earnings Before Interest and Taxes. EBIT corresponds to net revenue minus operating expenses (such as salaries, social charges, materials, energy, research, services, external services, advertising, etc.). It is the operating income for the Cegedim Group.

    *EBIT before special items:* This is EBIT restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the operating income from recurring operations for the Cegedim Group.

    *EBITDA:* Earnings before interest, taxes, depreciation and amortization. EBITDA is the term used when amortization or depreciation and revaluations are not taken into account. "D" stands for depreciation of tangible assets (such as buildings, machines or vehicles), while "A" stands for amortization of intangible assets (such as patents, licenses and goodwill). EBITDA is restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the gross operating earnings from recurring operations for the Cegedim Group.

    *Adjusted EBITDA :*  Consolidated EBITDA adjusted, for 2016, for the €4.0m of negative impact from impairment of receivables in the Healthcare Professional division

    *Net Financial Debt: *This represents the Company's net debt (non-current and current financial debt, bank loans, debt restated at amortized cost and interest on loans) net of cash and cash equivalents and excluding revaluation of debt derivatives.

    *Free cash-flow: *Free cash-flow is cash generated, net of the cash part of the following items: (i) changes in working capital requirements, (ii) transactions on equity (changes in capital, dividends paid and received), (iii) capital expenditure net of transfers, (iv) net financial interest paid and (v) taxes paid.

    *EBIT margin:* EBIT margin is defined as the ratio of EBIT/revenue.

    *EBIT margin* *before special items:* EBIT margin before special items is defined as the ratio of EBIT before special items/revenue.

    *Net cash:* Net cash is defined as cash and cash equivalent minus overdraft.


    About Cegedim:

    Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 4,200 people in more than 10 countries and generated revenue of €457 million in 2017. Cegedim SA is listed in Paris (EURONEXT: CGM).
    To learn more, please visit:
    And follow Cegedim on Twitter: @CegedimGroup, LinkedIn and Facebook.
    **Aude Balleydier*
    *Media Relations
    and Communications Manager
    Tel.: +33 (0)1 49 09 68 81 *
    **Jan Eryk Umiastowski*
    Chief Investment Officer
    and head of Investor Relations
    Tel.: +33 (0)1 49 09 33 36 *
    **Marina Rosoff*
    *For Madis Phileo*

    * *

    Media Relations
    Tel: +33 (0)6 71 58 00 34 * *


    *Follow Cegedim:*

    * *

    *  ** ** *


    · Cegedim_Results_1S2018_ENG.pdf Reported by GlobeNewswire 7 hours ago.

    0 0

    Angelo Katsoras, analysts at NBF Economics and Strategy argued that protectionism will outlast Trump regardless of who wins the midterms and the next presidential election in 2020.

    *Key Quotes:*

    "Protectionism will remain part of the American political landscape for the foreseeable future."

    "A quote from a letter sent last April by Democratic Senate leader Chuck Schumer regarding NAFTA negotiations to the Trump administration is a case in point: “I strongly believe that we should not miss this opportunity to protect our dairy producers from Canada’s recent predatory trade practices.”2 Further proof can be found in a bill recently passed with strong bipartisan support called the Foreign Investment Risk Review Modernization Act. This legislation not only strengthens the ability of the Department of Defense to decide who should be allowed to invest in the United States, it also makes it a lot harder for American companies to form joint ventures in countries like China, the main target of this legislation."

    " One of the very few things Democrats and Republicans agree on is that a tougher line should be taken against China’s trade policies. Democrats have veered left on many issues While much has been said about the Republican Party’s ideological shift under Trump, it is important to note that the Democrats, too, are undergoing a major realignment of their own. This can be seen from their growing support for government-provided health insurance, guaranteed income schemes and tuition-free education. A recent Gallup poll found that a higher percentage of Democrats had a more positive view of socialism than of capitalism." Reported by 7 hours ago.

    0 0

    Maryland individuals who purchase health insurance through the state's five-year-old Affordable Care Act exchange are poised to see the first decrease in their premium costs in 2019. Following federal approval of a program that aims to stabilize the ACA-born insurance market, Kaiser Permanente and CareFirst BlueCross BlueShield are seeking price decreases for their individual market plans. The drop follows four consecutive years of double-digit percentage hikes. Consumer advocacy groups present… Reported by bizjournals 4 hours ago.

    0 0

    A former operator of chiropractic offices in Hicksville and West Hempstead was charged Monday with fraud after officials said he billed a health insurance company for more than $2 million for services that were not performed. Reported by Newsday 2 hours ago.

    0 0

    Nine early-stage IoT, digital health, insurtech and fintech companies to compete for $5 million in investments at Yale School of Management in New Haven on October 18

    ROCKY HILL, Conn. (PRWEB) September 17, 2018

    Connecticut Innovations (CI), Connecticut’s strategic venture capital arm, today announced the finalists for VentureClash, the $5 million global venture challenge. The nine finalists, representing six different countries, will participate in a live pitch event at the Yale School of Management on Thursday, October 18, 2018, in front of a panel of live judges.

    The 2018 VentureClash finalists include:·     CloudKPI (Sandyford, Ireland): An insight engine that enables SaaS businesses to predict likely outcomes
    ·     DOZR (Kitchener, Canada): A marketplace for the online rental of heavy equipment
    ·     Invixium (Markham, Canada): A manufacturer of modern biometric solutions for markets needing strong user authentication, convenience and data analytics
    ·     IronYun (Stamford, Connecticut): A next-generation AI deep-learning, big-data video search business-to-business software company
    ·     Kasko (London, England): A digital insurance intermediary bridging the gap between the digital and insurance economies
    ·     Panoply (Tel Aviv, Israel): A smart data warehouse, using machine learning and natural language processing to automate data integration, data management and query optimization
    ·     Paygilant (Ramat Gan, Israel): A technology that prevents mobile payments fraud on mobile devices in the pre-authorization phase
    ·     SnapSwap (Luxembourg City, Luxembourg): Offers white-label end-to-end know-your-customer (KYC) services for financial institutions and businesses
    ·     Voiceitt (Ramat Gan, Israel): A proprietary speech-recognition technology translates unintelligible speech into clear speech in real time

    VentureClash brings together early-stage digital health, insurance technology (insurtech), Internet of Things (IoT) and financial technology (fintech) companies from around the world to compete for the opportunity to receive investment, mentoring, customer introductions, grants and services from CI to help them grow and succeed in Connecticut. A panel of judges will determine the distribution of the top investment award ($1.5 million) and the remaining $3.5 million on the day of the event.

    “This year’s VentureClash competition has already been another huge success in identifying young and promising companies and introducing them to all that Connecticut has to offer in support of their growth,” said Matt McCooe, CEO of Connecticut Innovations. “We congratulate all our finalists and look forward to the final pitch competition next month at Yale.”

    This year’s VentureClash attracted more than 300 companies from 20 countries around the world, all of whom completed initial applications this past June. Finalists were selected following two rounds of judging by an outside panel of industry leaders and subject matter experts. For more information on qualifications, requirements, guidelines and application, visit

    About VentureClash
    Managed by Connecticut Innovations, VentureClash is Connecticut’s global venture challenge focused on early-stage companies. The challenge identifies high-potential companies in digital health, fintech, insurtech and the Internet of Things that will receive investments from a $5 million investment award pool. Learn more at

    About Connecticut Innovations Inc.
    Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm and is the leading source of financing and ongoing support for innovative, growing companies. CI provides venture capital and strategic guidance for early-stage technology companies, and connections to its well-established network of partners and professionals. For more information, visit Reported by PRWeb 2 hours ago.

    0 0

    ‘Making a Real Difference’ for Independent Advisors, Clients for 30 Years

    ST. LOUIS (PRWEB) September 18, 2018

    Cutter and Company, a Registered Broker-Dealer and Investment Advisor, celebrates 30 years helping independent financial advisors establish and operate their own independent wealth management businesses this year. The firm was founded in October 1988 by CEO Deborah Castiglioni and President William Meyer, who share a deeply held belief that financial advisors who are free from the red tape, overbearing restrictions and income limitations of corporate employers and wirehouses, can serve their financial clients with greater results for all concerned.

    Cutter & Company, with headquarters located in Ballwin, Missouri, supports approximately 50 independent financial advisor practices. The firm strengthens independent practices by providing complete back office support, access to multiple custodians, a myriad of financial products to choose from, and making sure all compliance responsibilities are met - while giving them the freedom to develop their own preferred business model.

    The company also helps small and medium size businesses set up and manage group health insurance, qualified retirement plans and executive benefits. In addition, Cutter & Company helps individuals and families reach their financial goals – building wealth, paying for college, enjoying retirement and leaving something to the next generation.

    “It’s been a privilege to serve our advisors and their clients over these 30 years. We are focused on making a real difference in people’s lives. At the end of the day, that’s what it’s all about,” Meyer said.

    The Freedom of True Independence

    The firm has evolved and grown as changes occurred within the financial services industry over three decades, beginning at a time when most representatives offered products on a commission-basis to a time when fee-based advisory practices are more prominent. In addition, Cutter & Company weathered the serious market downturns of the “Tech Bubble” in 2001 and “The Great Recession” in 2008-‘09 without any lay-offs, a unique testament to the firm’s philosophy and approach.

    “Our industry is constantly evolving. So we must provide exceptional service to our independent advisors and help them in any way we can,” Castiglioni said. “That includes moving into holistic planning for clients.”

    Cutter & Company also has an extraordinarily clean record when it comes to regulatory compliance. The firm has been able to run a successful, compliant business in one of the most highly regulated industries.

    Foundation for the Future

    Cutter & Company is putting a succession plan in place for both the broker-dealer side of the business as well as the RIA practice to ensure the firm continues in the same direction the founders put in place 30 years ago. The firm operates without any debt and is well positioned to navigate future turbulent moves in financial markets. At all times, the focus is on honesty and integrity.

    Financial advisors who have a similar mindset are invited to reach out to Debbie or Bill for a personal conversation and to visit our website for more information at

    About Cutter & Company

    Serving independent financial advisors since 1988, Cutter & Company provides a family-like culture and flexibility to provide clients with the products and services most appropriate for them. We operate back office and compliance divisions that help grow and protect our independent advisor’s businesses. With our premier partnerships, we offer access to the same products and services as full-service retail firms, and financial stability that will give your clients confidence. To learn more call 636-537-8770. Reported by PRWeb 14 hours ago.

    0 0

    The American Animal Hospital Association (AAHA) and Petplan pet insurance are delighted to announce the launch of the AAHA Pet Health Insurance Program, offered by Petplan. Providing industry-leading illness and injury coverage for dogs and cats, the AAHA Pet Health Insurance Program offered by Petplan is now available to participating AAHA-accredited veterinary practices and their clients in the U.S. and Canada.

    NEWTOWN SQUARE, Pa. (PRWEB) September 18, 2018

    The American Animal Hospital Association (AAHA) and Petplan pet insurance are delighted to announce the launch of the AAHA Pet Health Insurance Program, offered by Petplan. Providing industry-leading illness and injury coverage for dogs and cats, the AAHA Pet Health Insurance Program offered by Petplan is now available to participating AAHA-accredited veterinary practices and their clients in the U.S. and Canada.

    AAHA has long made it their mission to advance the standard of veterinary excellence across the profession. As the only organization that accredits veterinary hospitals throughout the U.S. and Canada, AAHA sets the standard for quality veterinary care for companion animals. With the launch of the AAHA Pet Health Insurance Program offered by Petplan, the organization is working to mitigate stress in the veterinary hospital by helping pet owners manage the cost of care for their pets, and by helping veterinarians practice their best medicine without budgetary constraints.

    “When it comes to providing the best care for patients, a pet owner’s economic limitations can add stress to the equation,” said AAHA Chief Executive Officer, Michael Cavanaugh, DVM, DABVP (Emeritus). “Pet health insurance is important because it offers pet owners and practice teams another way to manage the cost of veterinary care and help pets get the care they need. At the end of the day, this helps reduce strain in the veterinary practice while simultaneously increasing pets’ access to care.”

    One key benefit of this new collaboration is an offer on Petplan pet insurance policies available to AAHA-accredited practices and their clients. In addition, Petplan provides a dedicated information hotline for all AAHA-accredited hospitals and clients so they can reach a Petplan service representative any time, day or night.

    “At Petplan, we want to help ensure that veterinarians are able to give pets the care they need,” says Steve Shell, co-CEO of Petplan. “In launching this new collaboration, we’re giving veterinary hospital teams the tools their clients need to understand the importance of pet insurance, and we’re providing a special offer to help the AAHA Pet Health Insurance Program offered by Petplan fit every budget. It’s our goal to ensure that more pets have worry-free illness and injury coverage from the start.”

    More than 1.5 million pets worldwide are covered by the Petplan brand, which is widely considered to be a top innovator in the pet insurance industry. Staffed with almost 200 dedicated pet lovers, the company strives to ensure healthier, longer lives for pets and peace of mind for their people. Policies for the AAHA Pet Health Insurance Program offered by Petplan will provide the same standard of worry-free protection.

    For more information about how AAHA and Petplan can support your practice and your clients’ pets, visit, email questions to, or call 800-212-2692.

    Petplan has built an industry-leading pet insurance policy for pet parents who demand a higher pedigree of care for their best friends. We’ve leveraged 40 years of global experience to create completely customizable coverage pet parents can feel confident in, and world-class claims service that operates 24 hours a day, every day.

    Petplan’s innovative approach to pet insurance has been recognized by Forbes, Financial Times, Bloomberg, Inc. magazine, Smart CEO, the Communicator Awards, Ernst & Young and many others.

    The American Animal Hospital Association (AAHA) is not an insurer and is not engaged in the business of insurance. Petplan policies are administered by Fetch Insurance Services, LLC (Fetch Insurance Agency, LLC in Michigan), d/b/a Petplan (Petplan Insurance Agency, LLC in California) and underwritten by XL Specialty Insurance Company in the U.S. and XL Specialty Insurance Company - Canadian Branch in Canada. For more information, visit Reported by PRWeb 13 hours ago.

    0 0

    Pro Football Hall Of Famers Threaten Boycott Until NFL Provides Health Insurance and Salaries Pro Football Hall Of Famers to boycott induction ceremonies if they don't get health insurance, cut of league revenue Reported by 10 hours ago.

    0 0

    Many high-profile Pro Football Hall of Famers said they would not attend the annual Hall of Fame induction ceremony until Hall of Famers receive health insurance and an annual salary that includes a share of league revenue. Reported by ESPN 11 hours ago.

    0 0

    It is unclear whether these benefits are being requested for all former NFL players or just Hall of Famers Reported by CBS Sports 9 hours ago.

older | 1 | .... | 916 | 917 | (Page 918) | 919 | 920 | .... | 952 | newer